GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Novo Nordisk A/S stock price ended at $122.75 on Thursday, after losing 1.43%.
(Updated on Apr 18, 2024)

Sell candidate since Apr 16, 2024 Loss -0.57% PDF

The Novo Nordisk A/S stock price fell by -1.43% on the last day (Thursday, 18th Apr 2024) from $124.53 to $122.75. During the last trading day the stock fluctuated 1.29% from a day low at $122.51 to a day high of $124.10. The price has been going up and down for this period, and there has been a -0.98% loss for the last 2 weeks. Volume has increased on the last day by 211 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $346.82 million.

Given the current short-term trend, the stock is expected to rise 15.21% during the next 3 months and, with a 90% probability hold a price between $141.42 and $166.90 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVO Signals & Forecast

There are few to no technical positive signals at the moment. The Novo Nordisk A/S stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $124.21 and $127.94. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -9.69%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Novo Nordisk A/S stock

Novo Nordisk A/S finds support from accumulated volume at $118.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $1.58 between high and low, or 1.29%. For the last week the stock has had daily average volatility of 1.82%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NVO) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Novo Nordisk A/S to open at $123.12, and during the day (based on 14 day Average True Range), to move between $120.18 and $125.32, which gives a possible trading interval of +/-$2.57 (+/-2.09%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 4.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $118.26 (3.66%) than the resistance at $133.07 (8.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Novo Nordisk A/S stock A Buy?

The Novo Nordisk A/S stock holds several negative signals and despite the positive trend, we believe Novo Nordisk A/S will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.346 Sell Candidate Unchanged

Predicted Opening Price for Novo Nordisk A/S of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$123.12 ( 0.300%) $122.75

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 124.70 1.59 %
R2 124.10 1.10 %
R1 123.72 0.793 %
Current price: 122.75
Support S1 122.51 -0.193 %
S2 122.14 -0.498 %
S3 121.53 -0.99 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 135.92 10.73 %
R2 133.49 8.75 %
R1 133.07 8.41 %
Current price 122.75
Support S1 118.26 -3.66%
S2 114.74 -6.53%
S3 109.02 -11.19%

NVO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 31, 2024 Mar 22, 2024 Apr 02, 2024 $0.93 0.735%
2 Aug 10, 2023 Aug 18, 2023 Aug 29, 2023 $0.88 0.93%
3 Feb 02, 2023 Mar 24, 2023 Apr 04, 2023 $1.19 1.50%
4 Aug 05, 2022 Aug 12, 2022 Aug 23, 2022 $0.584 1.10%
5 Mar 02, 2022 Mar 25, 2022 Apr 05, 2022 $1.04 1.80%

FAQ

What is the symbol for Novo Nordisk A/S Stock and on which exchange is it traded?
The symbol for Novo Nordisk A/S is NVO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Novo Nordisk A/S Stock?
The Novo Nordisk A/S stock holds several negative signals and despite the positive trend, we believe Novo Nordisk A/S will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Novo Nordisk A/S Stock?
Novo Nordisk A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novo Nordisk A/S Stock.

What's the current price of Novo Nordisk A/S Stock?
As of the end of day on the 2024-04-18, the price of an Novo Nordisk A/S (NVO) share was $122.75.

What is the 52-week high and low for Novo Nordisk A/S Stock?
The 52-week high for Novo Nordisk A/S Stock is $138.27 and the 52-week low is $75.56.

What is the market capitalization of Novo Nordisk A/S Stock?
As of the 2024-04-18, the market capitalization of Novo Nordisk A/S is 556.823B.

When is the next earnings date for Novo Nordisk A/S?
The upcoming earnings date for Novo Nordisk A/S is May 02, 2024.
Click to get the best stock tips daily for free!

About Novo Nordisk A/S

Novo Nordisk A/S Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ... NVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT